Our favorite super heroes Turbo & Scott star in a movie to bring awareness to #TSComplex: bit.ly/1V6LYKH
Follow
Novartis
@Novartis
Our purpose is to reimagine medicine to improve and extend people’s lives. See our community guidelines: bit.ly/2ITewHn
Novartis’s posts
With #machinelearning we hope to accelerate the drug discovery cycle, design better molecules and ultimately get transformative medicines to patients faster.
#reimaginingmedicine
May is #TSComplex Awareness Month. The more people who know, the better. Spread awareness w/ this Thunderclap bit.ly/1ELEkvH #IAMTSC
Join us in giving a warm welcome to , who from today is the new CEO of Novartis. Congrats Vas! #NovartisNews
We have one of the strongest R&D engines in the world. Every day, across the globe, we’re working to turn great science into transformative medicines.
#reimaginingmedicine
Bruno Strigini, Pres. of Novartis Oncology on the results we’re announcing at #ASCO16. bit.ly/22gsFjc
Today we announce Vas Narasimhan as new Novartis CEO from Feb 1, 2018. Thank you 👏 Joe Jimenez for your achievements bit.ly/2xJeD0W
The economic cost of chronic disease is big. The human cost will be bigger. That’s why we launched #NovartisAccess: bit.ly/2gHbBoy
The European Patient Innovation Summit is approaching! How can we empower people to use digital solutions to help manage #chronicconditions?
Expanding access to medicines, improving health equity and achieving net-zero carbon emissions are areas where we are accelerating efforts.
Read more on progress towards our #ESG targets: bit.ly/3mfceVs
#ESGinvestor #NovartisESG $NVS $NOVN
0:14
Breaking: Novartis appoints Elizabeth Barrett as the new CEO of Novartis Oncology – welcome Liz! #NovartisNews bit.ly/2EtCELV
How could combinations of drugs help overcome some of the biggest obstacles in #oncology?
#LungCancer #KRAS #MolecularGlues
The AI4HealthyCities Health Equity Network is reimagining how cities tackle heart health inequities – starting with New York. #healthequity #accesstohealthcare
BREAKING: Novartis receives FDA approval for a new treatment of HR+/HER2- advanced or metastatic breast cancer with a mutation. #NovartisNews
#BREAKING: Our first-in-class #CARTcell therapy is now approved in the EU. #NovartisNews bit.ly/2MSTTy5
BREAKING: The has approved our first-in-class #CARTcell therapy for a second indication. #NovartisNews bit.ly/2rdLLLv
Blurred vision, nausea & fatigue: #migraines are much more than a headache. #NotJustInYourHead #AANAM
0:05
Dedicated community healthcare workers like Dismus in Zambia are crucial for helping to #endmalaria. Learn more: bit.ly/2pBlqFz
Thanks to our partner for their support in developing the 1st child-friendly ACT to help #Endmalaria
Can you read this tweet without glasses? 1 billion others can’t either. We support this #WorldSightDay in working to put #VisionFirst bit.ly/2nmum5G
Rising drug resistance marks a new front in the fight to #endmalaria. See how we’re working to tackle this threat bit.ly/2ooqEVd
In rural #Mali, if you make it above 5 years old, you’re a survivor. That’s the reality of #malaria. #MalariaMustDie bit.ly/2pHkMax
GIF
Community healthcare workers are key in the fight to #endmalaria. Here’s a collection of scenes on the ground: bit.ly/2pBlqFz
Refugees make up 1/3 of Lebanon’s population, over-stretching health systems. We’re working with to help. cards.twitter.com/cards/18ce53un
BREAKING: Novartis receives European approval for the first treatment specifically designed for #migraine prevention #EMA #Neurology #NovartisNews bit.ly/2LB6JRG
The three-step immune response to cancer exposes new lines of attack on tumors: bit.ly/23z4a53 #AACR16
We’re here at Healthcare Conf., connecting with industry leaders and other innovators.
Reimagining medicine also means building #partnerships and new collaborations - working shoulder to shoulder with other scientists to bring medicines to patients globally. #JPMHC22
#Breaking: Novartis announces EU approval for ocular #genetherapy to treat an inherited retinal disease that leads to blindness #NovartisNews
A 3 million-molecule library, genome editing + tech partnerships... Discover R&D at Novartis: bit.ly/2kSnZmk #ReimagineMedicine
Join us on #WorldSickleCellDay to learn more about the condition from global experts and advocates as they come together for a FB Live panel discussion hosted on our page.
We’re joining the #sarcoma community this month to raise awareness & shout #SarcomaMatters bit.ly/29UIlbc
GIF
Cancer is on the rise worldwide. 100% of the ppl at #WMIF16 are dedicated to changing this: bit.ly/1ML16LI
These shocking figures are why we’re testing a new business model to help fight #chronicdisease bit.ly/2e6ygd3 #NovartisAccess
We’re all aiming for a cure... we must continue in these efforts —Bruno Strigini #WMIF16 bit.ly/1pBo4tw
Partnerships like with are how we are #ReimaginingHealthcare.
We developed ways of identifying individuals who survived one #CVD event and still have elevated levels of LDL cholesterol, putting them at risk for a second CVD event.
bit.ly/3NBh2AW #WEF2022
0:31
Discovering ways to help the MPN community is in our blood. Learn more about these rare blood cancers. cards.twitter.com/cards/18ce53un
Novartis researchers are using #virtualreality to get an up-close look at drugs and their targets bit.ly/2glwkMl #drugdiscovery
0:02
How to catch a mutant? Our researchers are taking on #chronicmyeloidleukemia with a 2-pronged attack: bit.ly/2nUNX8e #AACR17
0:04
“We need our teams to think about access early on. It’s not enough to develop an innovative medicine if there is no way for people to actually get access to it.” Patrice Matchaba #AccessinAction
. writes about his experience working as a doctor in Africa & passion for improving treatment access bit.ly/2eHvuwk
. has just named us #1 most innovative #biotech company & #21 across all industries. Here’s why: bit.ly/2oigQMI #ReimagineMedicine #NovartisNews
The growing burden of #chronicdisease in developing countries must be addressed today, not tomorrow.
We’re partnering w/ In collaboration w/ , to develop next-gen antimalarials. cards.twitter.com/cards/18ce53un
Personal stories. Eye opening facts. Energetic exchanges. Commitment to find solutions. All this and more at our recent Novartis Social Business access to healthcare dialogue. Watch the video. #NovartisAccess #talkingNCDs
Can social business improve global health? Novartis Chairman Joerg Reinhardt thinks the answer is yes. Here’s how: bit.ly/1P961Vh
The prevalence of #COPD is now increasing more rapidly in women than in men, yet it is still stereotyped as a male disease.
We’re working to understand the differences between men and women with COPD, to support equality in #respiratory health and improve outcomes #WorldCOPDDay
Through innovative strategies we’re working to make our medicines more affordable, so more people that need them can get them #AccessinAction
Migraine negatively affects time w/ family and friends. 45% reported missing family or social events #AHS17BOS bit.ly/2rTERei
GIF
We announce a strategic alliance with aiming to transform medicine with artificial intelligence. #ReimaginingMedicine #MicrosoftAI Learn more: bit.ly/2ogRxOB
1:39
“Against NCDs, we need all stakeholders to work together, including the private sector.” Jan Paehler #NovartisAccess
In Ghana, there are only 3 pediatric oncologists serving 27 million people. We’re working with to build more capacity to help children in Ghana suffering from cancer. #DayOfTheAfricanChild #AccessinAction
Congratulations to Novartis Oncology President, Dr. @susanneschaffe1, on her inclusion in this year’s list of Most Powerful Women! #FortuneMPW fortune.com/most-powerful-
I’m excited by the proactive steps being taken by our gov’t & Novartis in the fight against cancer. —
"I want nothing more than creating incredible innovations that reimagine medicines and then to get these medicines to the millions of people around the world who need them." - - Novartis CEO #AccessinAction
“Doing what’s legal is no longer enough. We have to do what’s right.” — our CEO Joseph Jimenez #NCD #globalhealth
#BreakingNews: Novartis receives FDA priority review for investigational biologic therapy for the prevention of #sicklecell disease pain crises. #NovartisNews Read more here: bit.ly/2XNVOFr
We’re pleased to announce the appointment of Susanne Schaffert, Ph.D., President of AAA and established Novartis executive, as our new CEO of Novartis Oncology. #novartisnews bit.ly/2Rc0eXi
#NovartisNews: FDA approves Novartis drug – new oral treatment approved in active Secondary Progressive #MS #SPMS
We’re proud to have delivered 300M child-friendly treatments to help combat #malaria. cards.twitter.com/cards/18ce53un
Self-care can help you control your #HeartFailure, and better manage symptoms. Read more: bit.ly/2x8hmiC
This Friday is #WorldHeartDay! Find out how to ‘share the power’ and get involved! #HeartFailure bit.ly/2fQQ2Qs
Discover why #NovartisAccess is teaming up with in Lebanon to fight #chronicdiseases cards.twitter.com/cards/18ce53un
By working together we’ve come this far to help #endmalaria. Find out about our contribution: bit.ly/2ooqEVd
0:10
No two people living with #HeartFailure are the same. That’s why the #HFPatientPerspective is important. Read more: keepitpumping.com/life-with-hear
This #WorldSickleCellDay it’s time to hear the untold stories of sickle cell disease and change how we see those speaking up. #UntoldSickleCellStories
18 local docs got trained, 120+ patients got treated in Shenyang, China thx to Orbis Flying Hospital #ProudMoments2016
#Alzheimers disease robs us of our most human qualities. For many families there is no hope and it is terrifying. RT to show your support for those affected by the disease. #AAIC18
We believe that Bio-Pharmaceutical companies should see themselves not just as producers of innovations, but as stakeholders that can partner directly with #Healthsystems to deliver better health outcomes.
#WEF2022 #Reimagininghealthcare #AccesstoMedicines
Chronic diseases soon to become leading cause of death in developing countries. #TalkingNCDs #NovartisAccess
